N. Sakuragawa et al., CLINICAL-STUDY OF TJ-137 TSUMURA KAMI-KIHI-TO IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), Clinical and applied thrombosis/hemostasis, 2(3), 1996, pp. 213-218
TJ-137 administered to patients with chronic the ITP increased the pla
telet count ''slightly'' or more in 31.7% of the patients and showed a
clinical effect in 40.9% with a rating of ''modestly effective'' or b
etter. With a low incidence of adverse reactions, TJ-137 is expected t
o be a new drug for the treatment of ITP.